Sponsor Pipeline

Corregene Biotechnology Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06358053 CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers Cervical Cancer Not Yet Recruiting
NCT06767046 KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors Colorectal Active, Not Recruiting
NCT07583316 A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell… Lung Cancer (Locally Advanced or Metastatic) Not Yet Recruiting
Disease Areas
Head & Neck Cancer (2) Lung Cancer (2) Cervical Cancer (1) Non-Small Cell Lung Cancer (NSCLC) (1) Liver Cancer (1)
Get alerts when Corregene Biotechnology Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free